CyPass Ultra System

Intraocular Pressure Lowering Implant

FDA Premarket Approval P150037 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Addition of the sinking spring, pa facility as an alternative manufacturing site for the cypass ultra system and implement changes to the inspection test methods and acceptance criteria for the stent delivery system.

DeviceCyPass Ultra System
Classification NameIntraocular Pressure Lowering Implant
Generic NameIntraocular Pressure Lowering Implant
ApplicantAlcon Research, Ltd
Date Received2018-06-25
Decision Date2018-07-23
PMAP150037
SupplementS010
Product CodeOGO
Advisory CommitteeOphthalmic
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Alcon Research, Ltd 6201 South Freeway fort Worth, TX 76134

Supplemental Filings

Supplement NumberDateSupplement Type
P150037Original Filing
S014 2019-12-20 Normal 180 Day Track No User Fee
S013
S012
S011 2018-07-16 30-day Notice
S010 2018-06-25 30-day Notice
S009 2018-05-04 30-day Notice
S008 2017-09-25 Normal 180 Day Track
S007 2017-07-27 Normal 180 Day Track No User Fee
S006 2017-06-02 Normal 180 Day Track No User Fee
S005 2017-04-20 30-day Notice
S004 2017-03-15 30-day Notice
S003 2016-11-03 30-day Notice
S002 2016-08-26 Normal 180 Day Track No User Fee
S001 2016-08-24 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00380657540075 P150037 008

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.